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Abstract
Purpose We investigated dimensions of low-income
minority patient engagement in the context of diabetes-
depression care-management with automated telephone
assessment (ATA) calls as a facilitator.
Methods Mixed method analyses (including regression
analyses and coding of interviews) were used to examine
patient engagement with technology, assess its impact on
health outcomes and satisfaction with care, and analyze
barriers to engagement. Patient engagement was measured
by analyzing patient’s ATA call response rates. We then
evaluated those results in the context of the outcomes of the
broader clinical trial, which compared three study arms.
Results Average completed call rate throughout the study
is about 50 % and decreases after 6 months. The biggest
barrier to patient engagement is timing. Patient engage-
ment levels differ by baseline depression status and have
no significant effect on health outcomes and satisfaction
with care at 6, 12, and 18 months. However, from the
preliminary clinical trial results, the arm in which the ATA
system is implemented has higher satisfaction with
depression care than the two control arms. Thus, it is more
likely that technology positively affects satisfaction with
depression care outcomes through provider engagement
rather than patient engagement.
Conclusions The study’s patient engagement results and
identified barriers would be useful to aid the design and
implementation of future automated screening and moni-
toring systems to optimize patient engagement. The results
also suggest that implementing a technology-supported
care-management might not result in outcome disparities
among patients with different levels of patient engagement.
Keywords Patient engagement  Diabetes complications 
Depression  Clinical trial  Prevention and control
Introduction
Diabetes doubles the risk of comorbid depression, espe-
cially among low-income minority patients [1–3]. The high
prevalence of depression with concurrent diabetes increa-
ses patient disability and need for social support, while
negatively impacting treatment efficacy, medication
adherence, risk of hospitalization, self-care-management,
patient–physician communication, and quality of life [4–6].
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Patients with a more active involvement in their health
care tend to have better outcomes and lower costs [7, 8].
Telehealth and Health Information Technology (HIT) hold
promise for increased patient involvement with care
through treatment monitoring and self-care behavior
prompting [9]; however, the role of patient engagement
with technology needed to be studied to elucidate better
design and implementation of telehealth to optimize patient
engagement, utilization, and health outcomes. For low-
income minority patients, one concern is whether imple-
menting telehealth will reduce or increase outcome dis-
parities among this disadvantaged population.
Patient engagement has been defined as a broad con-
cept including ‘‘activation; the interventions designed to
increase activation; and patients’ resulting behavior,’’
where activation ‘‘emphasizes patient’s willingness and
ability to take independent actions to manage their health
and care’’ [7]. In the telehealth domain, patient engage-
ment has been measured in terms of patients’ utilization
and interaction with the technology through which the
telecare is conveyed, i.e., in terms of usage and usage
patterns [10–12].
In this paper, we studied patients’ willingness to
manage their mental health within the telehealth domain
by investigating patients’ usage and usage patterns of a
depression telescreening and telemonitoring system.
Specifically, we investigated dimensions of patient
engagement in the context of safety-net diabetes-depres-
sion care-management with an automated telephone
assessment (ATA) as a facilitator. Patient engagement
was measured by analyzing each patient’s ATA call
response rates (percentage of completed or incomplete
calls divided by percentage of automated call attempts),
and their usage patterns over time (call response rates
over time) were also investigated. We used the patient
population from the technology arm of the Diabetes-
Depression Care-Management Adoption Trial (DCAT)
[13], which compared three different delivery modes of
depression care, including a technology arm that utilized
the ATA system.
The ATA system provides an innovative way to increase
patient engagement to provide critical data for cost-effi-
cient and effective clinical care to them [13, 14]. To ensure
the success of such systems in the future, we need to
understand the level of patient engagement in such sys-
tems, impact on health outcomes, and barriers to patient
engagement.
Such knowledge will improve the design and imple-
mentation of future systems, which in turn will enable
timely access to patient-reported health conditions and thus
more timely interventions to improve health outcomes.
Methods
Study overview and design
The DCAT clinical trial used a comparative effectiveness
research design to conduct a quasi-experimental study
comparing three delivery models for depression care in
three groups: usual care (UC), supported care (SC), and
technology-facilitated care (TC). The UC group repre-
sented the status quo of safety-net clinical practice. The SC
and TC groups provided care through the Los Angeles
County Department of Health Services (DHS) disease
management program (DMP), which uses team staff (such
as nurse practitioners, nurses, and social workers) to sup-
port chronic care-management. The clinical trial has been
described in a previous paper [13].
The TC arm tested a patient-centered ATA as a new
approach for depression care-management implementation.
The system uses advanced, scalable technology to collect
periodic patient-reported health data with diabetes patients
at risk for depression. These results are automatically
integrated with a disease registry and are used to prompt
the providers to facilitate more timely care-management to
patients in need. Figure 1 illustrates the DCAT technology-
facilitated care-management workflow and escalation sys-
tem in the TC arm. The ATA system properties have been
evaluated [14].
In the trial, the ATA calls consisted of six independent
modules of assessment, including depression symptom
monitoring using Patient Health Questionnaire 9-item scale
(PHQ-9), pain monitoring, self-care behavior prompting,
medication adherence assessment, behavioral therapy
practice monitoring, and patient request for provider to
contact them. This modulated design enabled a customized
call to each patient, as each module could be automatically
activated based on patients’ current information from the
patient registry. Details on the activation criteria for each
module have been described in a previous paper [14].
The ATA system was used to screen and monitor
depression symptoms of type 2 diabetes patients receiving
DMP care in three safety-net ambulatory care clinics
contained within DHS. These clinics made up the TC arm,
which included 444 patients enrolled in the study. Patients
received ATA calls in their language of preference: English
or Spanish. Patients were in the study for 18 months. In the
first 6 months, patients were in the DMP supported with
the ATA technology in which the DMP providers were
notified and tasked in near real time to address patients’
care needs. After 6 months, patients graduated from the
DMP and returned to their usual primary care. In months 7
through 12, they still received calls from the ATA system,
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but only selected results (e.g., symptoms of major depres-
sion) from the ATA calls were emailed to patient’s primary
care providers. Finally, in month 13 through 18, the
patients remained in usual primary care and no longer
received ATA calls. We conducted patient interviews to
evaluate health outcomes and satisfaction with care at
baseline and at the end of each of these time periods: at 6,
12, and 18 months after enrollment in the study.
Fig. 1 DCAT technology-facilitated care-management workflow and escalation system. (ATA = Automated telephone assessment)
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Patient recruitment
Patients for the DCAT study were identified from database
and clinic records and recruited from eight DHS primary
care clinics. The TC arm patients were recruited from three
of the eight primary care clinics. The patients for the study
were predominantly low-income, low-literacy, middle-
aged, Spanish-speaking Hispanic or Latino women who
had been diagnosed with diabetes for more than 5 years.
Patients were eligible for the study if they were aged
18 years or older with type 2 diabetes, had a working
telephone number, spoke English or Spanish, and read and
understood the consent form. Table 1 outlines the demo-
graphics and diabetes and depression characteristics of the
enrolled patients in the TC arm. The study’s human subject
protection protocols were reviewed and approved by the
Health Science Campus IRB of the University of Southern
California, and by Biomedical IRB and Education and
Research Institute IRB of the University of California, Los
Angeles.
Outcome assessment
Mixed method analyses were used to examine patient
engagement with technology, assess its impact on health
outcomes and satisfaction with care, and analyze barriers to
engagement. All outcome assessments focused on patients
in the TC arm, which was the intervention arm in the
DCAT trial that utilized the ATA system. However, we
also used a systems perspective to analyze the patient
engagement outcome assessment results by interpreting
them within the context of preliminary outcome results for
the whole trial.
Assessing effect of call characteristics and ATA program
duration on patient engagement
Patient engagement was measured by analyzing each
patient’s ATA call response rates (percentage of completed
or incomplete calls divided by percentage of automated call
attempts). Completed calls were defined as calls in which
patients were reached and answers to all questions were
recorded. Incomplete calls with and without Patient Health
Questionnaire (PHQ)-9 indicated differing levels of patient
engagement: Incomplete with PHQ-9 indicates that patients
picked up the call and answered all PHQ-9 questions but did
not complete the rest of the call (i.e., did not finish answering
the rest of the modules in the call), while incomplete without
PHQ-9 indicates that patients picked up the call and did not
answer all PHQ-9 questions before hanging up.
To evaluate how call characteristics and duration on the
ATA program affect patient engagement, we assessed whe-
ther patient engagement levels differed between English and
Spanish language calls, whether patient engagement levels
differed between calls with different numbers of modules,
and whether patient engagement levels changed over time.
As aforementioned, patients received ATA calls in the first
12 months they were in the study, but after 6 months, the ATA
call results were no longer integrated with their DMP care as
patients graduated from the DMP program after 6 months.
Therefore, we wanted to examine whether patient engagement
levels in the technology could be sustained beyond their par-
ticipation in intensive DMP care-management, but with lim-
ited involvement of primary care physicians. To do that for
each patient, we tabulated the number of completed calls and
total calls received in the first 6 months and second 6 months
they participated in the study, and calculated the percentage of
completed calls for each period. Then, we averaged the per-
centage of completed calls across all patients for each period
to obtain and compare the percentage of completed calls in the
first 6 months and the second 6 months of the study.
Barriers to patient engagement
To analyze barriers to patient engagement, patients with
incomplete calls were followed up with a human call to
determine reasons for failure to contact. We then coded and
tabulated the reasons for incomplete calls from these patient
interviews. Additionally, to gain a more complete picture of
patient engagement, we also obtained the providers’ per-
spectives on supports and barriers to patient engagement by
interviewing providers in the study clinics. We conducted
semi-structured, open-ended interviews with the providers
and analyzed the responses to find common themes on
possible systemic barriers to patient engagement.






Female 273 (62 %)
Age 52.59 (8.90)
Hispanic/Latino 400 (91 %)
A1C value 9.69 (1.94)
On insulin treatment 288 (65 %)
Toolbert diabetes self-care in the
past 7 days (range 0–7)
4.23 (1.24)
PHQ-9 score 10 or greater 116 (26 %)
PHQ-9 total score (possible range 0–27) 6.37 (5.95)
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Statistical analyses to evaluate effects of patient
engagement
Statistical analyses were performed to evaluate whether
patient engagement levels differed by baseline depression
status, and to assess the effect of patient engagement levels
on health outcomes and satisfaction with care at 6, 12, and
18 months, controlled for baseline measures. To do this, the
completed call rate for each patient was calculated, and a
binary indicator for having a [ 50 % completed call rate
created as a variable indicating patient engagement.
To evaluate whether patient engagement levels differed
by baseline depression status, logistic regression was per-
formed, with the dependent variable being a [ 50 %
completed call rate and the independent variable being
baseline depression status (depressed = PHQ-9 at baseline
[10), controlling for baseline covariates (age, preferred
language, gender, insulin, onset age of diabetes, BMI,
study clinic).
To assess the effect of patient engagement levels on health
outcomes and satisfaction with care at 6, 12, and 18 months,
we performed logistic (for binary outcomes) or ordinary
linear regression (for continuous outcomes), with the
dependent variable being the health outcome or satisfaction
with care in question at 6, 12, and 18 months, and the inde-
pendent variable being the [50 % completed call rate,
controlled for baseline covariates and the baseline value of
the health outcome and satisfaction with care being assessed.
Patient engagement results within the context of the results
of the overall clinical trial
To obtain a fuller picture of how the patient engagement
results in the preceding sections fit within the context of the
larger clinical trial, we presented some preliminary out-
come results from the clinical trial. The preliminary out-
comes evaluation compared the depression outcomes and
satisfaction with depression care between the technology-
supported intervention arm and the two control arms in the
clinical trial. A generalized propensity score method for
interpreting multiple-intervention-arm quasi-experimental
studies was applied to analyze the 6-month outcome.
Baseline characteristics that might influence outcomes
were used to estimate the propensity score, and then the
propensity scores were used in regression models as
covariates to predict comparative treatment effectiveness.
Specifically, by analyzing the patient engagement ana-
lysis results through the lens of the outcome evaluation in
the larger context, we could understand the pathway
through which the technology-supported care-management
intervention impacted health outcomes, and could deter-
mine whether patient engagement is an important part of
that pathway.
Results
How call characteristics and duration on the ATA
program affect patient engagement
Rates of patient engagement
During the study, 3,180 automated calls were made during
an 18-month period (10/20/2011–7/4/2013). Of these,
around 50 % were completed calls, 20 % were incomplete
(either with or without PHQ-9), and 30 % (coded as ‘‘oth-
ers’’ in Table 1) were not picked up or reached (discon-
nected numbers, expired call attempts, or reached answering
machine) or were rescheduled (Table 1). The majority of
incomplete calls (84 %) were incomplete without PHQ-9.
The rates of completed calls were similar for English
calls and Spanish calls. The rate for total incomplete calls
was slightly higher for Spanish calls than for English calls.
Rates of patient engagement with number of modules asked
As can be seen in Table 2, the rates of completed calls and
incomplete with PHQ-9 calls were highest for calls in
which six modules are asked. Patients who were not on
anti-depressive medication (AM) or psychotherapy were
asked four modules, and those on AM or psychotherapy
were asked five modules. Those on AM and psychotherapy
were asked all six modules. Patients asked all six modules
may have been more motivated (thus their engagement in
two forms of depressive treatment) and consequently may
have had a higher degree of patient engagement.
Rates of patient engagement over time
The rate of completed calls was higher for patients who were
in the first 6 months of the study than for patients in the
second 6 months of the study (Table 3). Patients’ motivation
to complete calls might have decreased over time due to
boredom from the repetition of the calls or less interaction
with their providers (since patients leave the DMP after
6 months in the study and DMP providers no longer follow-
up with patients based on the results of the ATA calls). This
potentially indicates the importance of having provider
support the ATA technology to keep patient engaged.
Patients’ perspective: barriers to patient engagement
All patients with incomplete calls were contacted for this
analysis, and 282 out of 284 patients (99 %) were reached.
Of these 282 patients, 43 % cited inconvenient call time as
the reason for not completing the automated call, whereas
57 % of patients did not complete the automated calls due
to preference for human calls, bad cell phone connection,
Qual Life Res (2015) 24:1119–1129 1123
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disconnected phone, non-working phone, and/or personal
reasons. In other words, most incomplete calls were due to
timing issues for the call (patients were busy at the time of
the call or were not at home, or other timing issues).
Although there is a larger segment of issues due to the need
for human interaction and technology issues, the greatest
single reason for not reaching patients is timing issues.
Reasons for failure to complete the calls and the incidence
for each reason are tabulated below.
Providers’ perspective on patient engagement
A total of 12 interviews were conducted with providers in
the technology-supported care arm: three social workers, a
medical doctor, two registered nurses, a nurse practitioner,
and two physicians’ assistants, in addition to three site
clinic/leadership staff.
Three themes related to patient engagement emerged in
the interviews: perceived supports for patient engagement,
perceived barriers for patient engagement, and the shift of
care behavior toward increased engagement with patients
and toward increasing patient engagement.
In terms of perceived supports for patient engagement,
providers conveyed that patients felt like someone was ‘‘on
their side’’ and that they had care providers looking out for
them beyond usual care. According to providers, patients
felt an improved sense of connection especially because they
felt that they could always reach someone when needed.
An excerpt from the interview on this theme is given
below:
A: I think the DCAT program is good in evaluating
depression in all patients with chronic disease and
also in giving them the sense that there is someone
beyond their primary care physician who can facili-
tate care for them, who they could reach out to in
times of stress or depression or whatever, and get the
attention that they needed in a timely fashion.
In terms of perceived barriers for patient engagement,
providers stated that patients sometimes were unaware of
why these calls were coming because of a possible lack of
clear instructions during recruitment or that they simply
forgot. This is supported by the results from our follow-up
with patients with incomplete calls, in which 20 patients
cite study-related reasons (lack of clear instructions, forgot
about being in a study, and so on) as the reasons for
incomplete call.
An excerpt from the interview on this theme is given
below:
Q: And what would you change? I mean we talked
about several things.
A: Yeah just the phone thing, the disclosure to the
patients. I really you know and again I wasn’t in the
room when the recruiters talked to them but I think
some patients will say yes to anything. They will. I
mean I call them by the wrong name and they say yes
and then I find out it’s the wrong name. I think it has
to be like almost making sure that they’re looking in
your eyes saying, ‘Do you understand this is going to
be in your house? They’re going to call’. And then
later when they call, I would say, you knew they were
going to call. They tell you, ‘Oh we didn’t understand
or I didn’t know what she meant.’ You know, so I
don’t know if it’s a signature they need or just the
disclosure. Once they know, I think they’re okay that
this is what’s going to happen.
Finally, providers also reported that the technology helped
shift their care behavior from focusing on screening and
monitoring to treating patients who need it, increasing their
engagement with patients, as can be seen in the excerpt
below:
A: I really think on our side, I think it was great for the
patients. We really were more proactive with medication.
Table 2 Rates of patient
engagement by language and
number of modules asked
Call status Language No. of modules
English Spanish Grand total 4 5 6
Complete 48.79 % 49.04 % 48.99 % 49.37 % 47.00 % 59.15 %
Incomplete w/o PHQ-9 24.14 % 26.54 % 26.10 % 26.50 % 25.25 % 22.54 %
Incomplete w/PHQ-9 3.45 % 3.58 % 3.55 % 3.77 % 3.00 % 2.82 %
Others 23.62 % 20.85 % 21.35 % 20.36 % 24.75 % 15.49 %
Total calls 580 2,600 3,180 2,309 800 71









Month 0–6 875 1,582 55.31
Month 7–12 683 1,598 42.74
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We were more zoned in on what does, you know, how is
this going to affect the patient? Where before it was like,
oh they scored a two, okay let’s go onto the next level.
This shift of some of the screening and monitoring burden
to technology also allows some providers to spend more
time getting patients to be more engaged in their care and
open up more in their interactions with the providers, as
revealed in the excerpt below:
Q1: Doing this monitoring of depression, has that
changed your awareness of the population?
A: Personally, for me, I think I have put in a little bit
more effort to get on a little more involved in the
patient so that they can express to me and feel con-
fident that this information is just here, it’s not spoken
publicly, and I’ve dealt with the issue.
Q2: So it’s kind of like building some trust so that
they can be able to talk to you a little bit more.
A: Correct. And I think, after your DCAT program,
I’ve been a little bit more sensitive to that aspect of it,
and I really thank you for that.
Evaluating the effect of patient engagement levels
Tables 4 and 5 show the significant results from our evalu-
ation of the effect of patient engagement on health outcomes
and satisfaction with care. Tables for outcomes that are not
significant are included in the supplemental materials.
Evaluating whether patient engagement differs by baseline
depression status
As can be seen in Table 4, patients who had a PHQ-9 score
of ten or higher at baseline were less likely to be engaged
with the ATA technology; i.e., depressed patients were less
likely to reach [50 % completed call rate than non-
depressed patients [OR = 0.608 (0.389, 0.950)].
Evaluating the effect of patient engagement on health
outcomes and satisfaction with care
Patient engagement (having [50 % completed call rate)
did not have a significant effect on depression status at 6,
12, and 18 months (p [ 0.05 for all three time periods).
Patient engagement also did not have a significant effect on
patients’ diabetes self-care at 6, 12, and 18 months
(p [ 0.05 for all three time periods). Patient engagement
also did not have a significant effect on patients’ satisfac-
tion with depression care and satisfaction with diabetes
care at 6, 12, and 18 months (p [ 0.05 for all three time
periods).
Table 4 Barriers of patient engagement from the patients’
perspective
Human call Count Percent
Wants human calls/does not like automated calls 14 4.9
Non-study-related reasons
Busy/was not home/timing issues 122 43.1
Wrong number 10 3.5
Bad connection/got disconnected 11 3.9
Hung up by accident 2 0.7
Gave friend’s/family’s number 3 1.1
Someone else answered/does not remember
receiving call
17 6.0
Phone was not working/battery dead 3 1.1
Phone does not accept incoming calls 1 0.4
Low on cell phone minutes 1 0.4
Said she did answer call (although no record of
answers in DMR)/repeat entries with final being
answered/states answered but on incomplete
sheet
14 4.9
Called on christmas 1 0.4
Gave new number 1 0.4
Study-related reasons
Does not want to be bothered 1 0.4
Did not remember about study/does not know what
the ATA was
6 2.1
Confused about pin 1 0.4
Tech problem 4 1.4
Does not like questions 2 0.7
Graduated/dismissed/no longer goes to study clinic 3 1.1
Call confusing b/c did not say what it is for 1 0.4
Thought another study whose machine was broken 1 0.4
Thinks that after 6-month follow-up, no need to
answer ATA calls
1 0.4
MRN coded twice for same person 1 0.4
Personal reasons
Personal reasons (e.g., family member in hospital) 3 1.1
In pain/too sick to move/sick 9 3.2
Depressed 1 0.4
Hard of hearing 3 1.1
Not technologically savvy 2 0.7
Thought it was fraud 1 0.4
Do not want to answer over phone 1 0.4
Felt fine, not depressed 2 0.7
Disappointed in care provided 1 0.4
Failed to locate patient
Failed to locate patient/incomplete 23 8.1
Disconnected 14 4.9
No entry on sheet 1 0.4
Passed away 1 0.4
Partial entry on sheet 3 1.1
Answering machine for different person 1 0.4
Total 283
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Putting the patient engagement results in the context
of the results of the overall clinical trial
Our analyses of the overall clinical trial (not shown) found
both TC and SC significantly improved satisfaction with
care for emotional problems (at p \ 0.05). Moreover, the
difference between TC and SC is also significant (at
p \ 0.05), indicating that patients in the TC arm were
significantly more satisfied with their depression care than
those in either SC or UC.
Comparing the three arms, TC resulted in better satis-
faction with depression care outcomes at 6 months than the
control groups (SC and UC). However, patient engagement
within the TC group did not affect this outcome significantly
within the TC group. Our other analysis of patient satis-
faction with the ATA calls can shed some lights on this
result (manuscript in preparation). At the 6- and 12-months
follow-up interviews, the vast majority of the TC patients
(80 % or more) perceived the ATAs as being ‘‘usually’’ or
‘‘always’’ easy to use. Three quarters of the patients did not
feel that the ATA calls were a bother. However, the per-
centages of patients who felt that the ATAs were ‘‘usually’’
or ‘‘always’’ useful in empowering them to access providers
or to remind them of self-care activities were moderate:
average at 61 % at 6 months and 49 % at 12 months.
Thus, it is likely that the DCAT technology does not
positively affect satisfaction with depression care outcomes
through patient engagement but through other pathways,
since patient engagement does not affect satisfaction with
depression care significantly in the TC group, and pre-
liminary results on the patient satisfaction with the ATA
calls indicate that patients’ perception of the direct use-
fulness of ATA system to them is only moderate. Instead, it
is possible that the DCAT technology affects satisfaction
with depression care positively by increasing provider
engagement through the integration of the ATA technology
results into the care-management system. For example,
tasks automatically generated based on ATA call results
might have resulted in more provider-involved care for all
patients in TC group regardless of each patient’s engage-
ment with the technology and may have led to higher
satisfaction with depression care for all patients in the TC
group without a significant differential effect due to dif-
fering levels of patient engagement.
In other words, based on these results, we hypothesize
that rather than increasing patient engagement directly, the
pathway by which TC improves satisfaction with depres-
sion care results is an increase in provider engagement,
perhaps through the change in their clinical microsystems
of how they identify and treat patient care needs due to
technology support in care-management. This increase in
provider engagement then possibly increases patient
engagement.
Some insights from the provider interview lend support
to this hypothesis. As shown in some of the excerpts in
section ‘‘Evaluating the effect of patient engagement lev-
els,’’ some providers feel that the DCAT technology makes
them more sensitive to patient needs and having the tech-
nology support the screening and monitoring allows them
to spend more time adjusting depression therapy, increas-
ing their engagement. Also, it makes them more sensitive
to patient needs and gets them to try to increase patient
interaction during care appointments, increasing patient
engagement.
In addition, preliminary results from surveys of the
providers in the study indicate that providers in the tech-
nology arm have higher outcome expectancy and self-
efficacy than those in the non-technology arm [15]. Both of
these factors are linked to increased engagement and better
performance in social cognitive theory [16, 17]. In terms of
the manifestation of these factors in provider behavior, the
results of the survey back the insights from the provider
interviews: more providers in the technology arm educate
patients about depression, discuss management options,
monitor adherence and side effects, and adjust depression
therapy compared to those in the non-technology arms,
while they assess for depressive episodes less (likely due to
the shift of the burden of depression assessment to the ATA
calls in the technology arm) [15]. These shifts in providers’
outcome expectancy and self-efficacy, as well as the shift
in provider behavior from assessment to education and
care-management (which may facilitate shared decision
making) in the technology arm might be the reason why
patients in turn are more satisfied with care in the TC arm.
This hypothesis would need to be empirically evaluated in
future research.
Compared to UC, both TC and SC are shown to sig-
nificantly improve depression outcomes, and TC is shown
to significantly improve satisfaction with diabetes care.
Table 5 Odds ratio estimates for logistic regression with patient
engagement (more than 50 % call completion rate) as dependent
variable and depression status at baseline as independent variable,






Age 0.992 0.960 1.025
Spanish 0.797 0.474 1.340
Sex 1.063 0.702 1.610
Insulin 1.089 0.704 1.686
Onset age 0.997 0.967 1.027
BMI 0.979 0.952 1.007
Study site 1.011 0.668 1.530
Depressed at baseline 0.608 0.389 0.950
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However, TC is not significantly different to SC in terms of
depression outcomes and satisfaction with diabetes care.
Nevertheless, it is important to note that this does not mean
that the DCAT technology might not have any impact on
these particular outcomes compared to SC, because DCAT
technology integrated care in a way that changed the pro-
viders’ workflow; therefore, as the DMP care delivery in
TC was different from care delivery in SC. Providers in the
TC arm were able to shift their care to those who needed it
more because screening and monitoring for low-risk
patients were supported by the technology [15]. DCAT
technology to support DMP care might be a viable option
to the usual care in overstretched DMP clinics.
That the patient engagement results do not show sig-
nificant effect of patient engagement on these outcomes in
the TC group indicates that the implementation of such a
technology for depression care to support DMP care might
not result in disparity of outcomes among patients of dif-
fering levels of patient engagement. However, there might
be a minimum threshold of overall patient engagement in
the system for the results to hold; i.e., there might be a need
for enough patients to be engaged to affect provider
engagement significantly such that providers’ shift in
workflow due to the DCAT technology will not impact
outcomes negatively. What this minimum threshold might
be warrants further study.
Discussion
A question that surfaces from the results is whether there is
a minimum threshold required for patient engagement in
ATA-supported systems for the system to benefit as a
whole. This requires further study. However, if the mini-
mum threshold indeed exists and patient engagement levels
do not have a significant effect on health outcomes at the
individual level, then the implication is that we may not
need to activate patients to be engaged at the individual
level since there is no disparity of care that results from
differing levels of patient engagement once the minimum
threshold is met. Rather, less expensive and simpler-to-
implement activation efforts that target the entire group of
patients may be appropriate.
Another metric of patient engagement that we consid-
ered with this dataset is the number of requests to talk to
nurse/social worker made through the ATA calls, as this
might be an indication of patients being more active in
gaining information for their depression care. However,
using that metric is problematic since we find that many of
these requests were accidental or they actually meant to
talk to the study assistant instead. Also, anecdotal evidence
from providers in the study clinic also suggest that many
patients either call the clinic or call the direct line or mobile
number of particular health care providers directly instead
of going through the ATA to request to talk to a nurse/
social worker, making the considered metric not reflective
of the actual number of interactions patients have with their
providers, since we do not have a record of the direct calls
made outside the ATA system.
We are also analyzing the results of patient surveys in
the TC arm that examines the impact of ATA on patient
activation, i.e., how the ATA helps in making them feel
more active and empowered in their depression care (by
being more aware of how one is feeling, being reminded to
take care of health, feeling better connected with provid-
ers). The preliminary results, as aforementioned, show
moderate effects, albeit further analysis is still ongoing.
This work, which examines another aspect of patient
engagement piece, will complement the results of this
paper in painting a better picture of the role of patient
engagement in the DCAT study.
Diabetes and depression, as chronic diseases, require
preventive and self-care activities, and the way care is
delivered and patient is engaged can influence patients’ self-
care abilities [18]. Thus, even though our study did not
demonstrate patient engagement to be an important predictor
in the TC group, it is still important to examine barriers to
engagement, as the results would also apply to other auto-
mated call systems to support care. Additionally, learning
about these barriers will help us understand how to change
the ATA system design and delivery to remove some of these
barriers; this will be important if there is indeed a minimum
threshold required for patient engagement, and a new system
needs to ensure that the threshold is met.
As an example, most patients with incomplete calls cited
timing issues as a major barrier, even though the ATA calls
were adapted to specific patient time preferences, and
multiple calls were made if patients were not reached with
the first call. Patients were asked their preferred call day
and time when ATA calls were configured. However, when
the first call was missed, the ATA system tried again once
every 3 h between 8 AM and 8 PM regardless of call time
preference, and these callback times might not have been
convenient to patients. Possible solutions to reduce the
barrier to patient engagement due to timing issues may
include allowing patients to call back at a time of their own
choosing if calls are missed, or configuring the system to
call back only at times that are convenient for each indi-
vidual patient.
About 10 % of patients with incomplete calls cited
study-related reasons as the barrier. To reduce this barrier,
patients should be given instructions that are easy to read,
understand, and remember. These instructions could be
given either during the recruiting session for the study or
during enrollment into the program. This solution would
also be relevant if such a system was to be implemented in
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the real-world setting, as it highlights the need to provide
clear instructions and provide reminders to answer the calls
to patients in the beginning of the implementation.
The system should also take into account personal rea-
sons for incomplete calls and possibly personalize the ATA
system further to accommodate different needs of patients.
For instance, hard-of-hearing patients could potentially be
provided specific prompts, and patients who are sick could
be given calls or monitoring to receive calls at a more
optimal time.
At the second level of engagement in the framework for
patient and family engagement in health care, organiza-
tions should ‘‘reach out for consumer input to ensure that
they will be as responsive as possible to patients’ needs.’’
[19]. Thus, future iterations of ATA should incorporate
refinements from the patient feedback obtained through
post-study evaluations such as this study, but also through
pre-study patient input such as focus groups to determine
how to best design the technology to meet patient needs.
It is also worth noting that levels of patient engagement
decline after the first 6 months. It seems that to sustain
patient engagement over the long run, provider support, or
other ways to activate patient engagement may be necessary.
The results of our patient engagement analysis, put in the
context of the preliminary outcome results from the DCAT
trial, highlight the possibility that provider engagement
plays an important role in the pathway of the impact of the
DCAT system on outcomes. Our current, ongoing work
involves analyzing provider engagement in the DCAT study
to investigate this pathway. This pathway might explain why
the system as a whole may benefit (in terms of satisfaction
with care in this case) despite disparities in levels of patient
engagement within the system, as the increased provider
engagement benefits all patients in the clinics.
Conclusions
In this paper, we have investigated various dimensions of
patient engagement with an ATA technology, examined
barriers to patient engagement from the patients’ and pro-
viders’ perspective, assessed the impact of patient
engagement levels on health outcomes and satisfaction
with care, and evaluated the results in the broader context
of the clinical trial results. The patient engagement results
and barriers that we found would aid the design and
implementation of future automated screening and moni-
toring systems to optimize patient engagement.
Our results also raise an interesting implication that
implementing a technology-supported care-management
might not result in disparity of outcomes among patients of
different levels of patient engagement and that the system may
benefit as a whole despite disparities in levels of patient
engagement within the system. Our analysis also hints at a
pathway in which satisfaction with depression care is
improved through increased provider engagement, which
consequently might increase patient engagement; this
hypothesis should be empirically evaluated in future research.
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